826

ANTI-INTEGRIN αVβ6 AUTOANTIBODIES ARE A NOVEL PREDICTIVE BIOMARKER IN ULCERATIVE COLITIS

Date
May 8, 2023
Explore related products in the following collection:

Loading...

Tracks

Related Products

Thumbnail for MYELOID CELL DYSREGULATION ASSOCIATES WITH NON-RESPONSE TO ANTI-TNF THERAPIES.
MYELOID CELL DYSREGULATION ASSOCIATES WITH NON-RESPONSE TO ANTI-TNF THERAPIES.
The pathogenesis of inflammatory bowel disease (IBD) involves crosstalk between genetic and microbial factors that influence immune reactions. Tofacitinib, a pan JAK-STAT inhibitor, is a small molecule indicated for the treatment of moderate-to-severe ulcerative colitis (UC)…
Thumbnail for EARLY LIFE EXPOSURE TO PARENTAL CROHN'S DISEASE IS ASSOCIATED WITH ALTERED GUT MICROBIOME COMPOSITION, IMPAIRED GUT PERMEABILITY, AND INCREASED RISK OF INCIDENT CROHN'S DISEASE
EARLY LIFE EXPOSURE TO PARENTAL CROHN'S DISEASE IS ASSOCIATED WITH ALTERED GUT MICROBIOME COMPOSITION, IMPAIRED GUT PERMEABILITY, AND INCREASED RISK OF INCIDENT CROHN'S DISEASE
BACKGROUND: Cancer is a major cause of morbidity and mortality in persons with inflammatory bowel disease (IBD). We evaluated temporal trends and relative risks of intestinal and extra-intestinal cancers among persons with IBD and matched controls…
Thumbnail for VEDOLIZUMAB RESPONSE IN ULCERATIVE COLITIS ASSOCIATES WITH LYMPHOID AGGREGATE ATTENUATION THROUGH IMPAIRED RECRUITMENT OF NAÏVE LYMPHOCYTES
VEDOLIZUMAB RESPONSE IN ULCERATIVE COLITIS ASSOCIATES WITH LYMPHOID AGGREGATE ATTENUATION THROUGH IMPAIRED RECRUITMENT OF NAÏVE LYMPHOCYTES
The pathogenesis of inflammatory bowel disease (IBD) involves crosstalk between genetic and microbial factors that influence immune reactions. Tofacitinib, a pan JAK-STAT inhibitor, is a small molecule indicated for the treatment of moderate-to-severe ulcerative colitis (UC)…
Thumbnail for ANTI-GRANULOCYTE MACROPHAGE-COLONY STIMULATING FACTOR AUTOANTIBODIES ARE ASSOCIATED WITH DEVELOPMENT OF COMPLICATIONS IN RECENTLY DIAGNOSED CROHN’S DISEASE PATIENTS
ANTI-GRANULOCYTE MACROPHAGE-COLONY STIMULATING FACTOR AUTOANTIBODIES ARE ASSOCIATED WITH DEVELOPMENT OF COMPLICATIONS IN RECENTLY DIAGNOSED CROHN’S DISEASE PATIENTS
BACKGROUND: Anti-granulocyte macrophage-colony stimulating factor autoantibodies (anti-GM-CSF) have been associated with development of Crohn’s disease (CD) and complications at time of diagnosis. There are limited data on anti-GM-CSF as a prognostic biomarker in CD…